The Orthopedics and Tissue Technologies group of Integra LifeSciences Holding Corporation has signed a three-year group purchasing contract with Premier, Inc. The agreement will offer small bone orthopedic implants to Premier alliance members.
“I’m confident this newly established partnership will allow us to build a strong and lasting relationship with Premier, ” said Mark Augusti, corporate vice president and president, Integra Orthopedics and Tissue Technologies. “This mutually beneficial agreement marks a significant opportunity for both our organizations and reflects our commitment to provide Premier members with the highest quality products and service for upper and lower extremity patients.”
Integra’s small bone implants are used to treat common degenerative conditions of the foot and hand resulting from arthritis and diabetes. This is the company’s first agreement of this type and is a first step in Integra’s effort to develop larger enterprise agreements to support the company’s future growth plans over the next five years..
While the new agreement has the potential to contribute significantly to the growth of Integra’s Extremities business in 2015 and beyond, the company does not expect this contract to have a significant impact on 2014 financial results.
